Fibromax and inflamatory markers cannot replace liver biopsy in the evaluation of non-alcoholic fatty liver disease.
Lardi LL, Lul RM, Port GZ, Coral GP, Peres A, Dornelles GP, Branco F, Fernandes S, Leães CG, Mattos AA, Buss C, Tovo CV.
Lardi LL, et al. Among authors: peres a.
Minerva Gastroenterol (Torino). 2022 Mar;68(1):85-90. doi: 10.23736/S2724-5985.20.02746-4. Epub 2020 Jul 22.
Minerva Gastroenterol (Torino). 2022.
PMID: 32700499